Philip S Helliwell Selected Research

Philip S Helliwell Research Topics

Disease

65	Psoriatic Arthritis 03/2024 - 07/2005
22	Psoriasis (Pustulosis Palmaris et Plantaris) 03/2024 - 07/2005
14	Pain (Aches) 03/2024 - 07/2002
11	Fatigue 01/2023 - 05/2007
10	Arthritis (Polyarthritis) 01/2023 - 05/2007
8	Rheumatoid Arthritis 12/2016 - 07/2002
7	Chronic Disease (Chronic Diseases) 01/2023 - 01/2021
7	Inflammation (Inflammations) 09/2022 - 07/2008
5	Necrosis 01/2022 - 06/2013
4	Skin Diseases (Skin Disease) 09/2022 - 05/2011
3	Ankylosing Spondylitis 09/2022 - 02/2010
3	Congenital Abnormalities (Deformity) 09/2012 - 07/2002
2	Uveitis 03/2024 - 12/2021
2	Spondylitis 08/2023 - 01/2020
2	Axial Spondyloarthritis 08/2023 - 01/2021
2	Sacroiliitis 09/2022 - 10/2021
2	Nail Diseases (Nail Disease) 01/2022 - 05/2007
2	Opportunistic Infections (Opportunistic Infection) 12/2021 - 01/2021
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2021 - 01/2021
2	Infections 01/2021 - 01/2020
2	Shoulder Impingement Syndrome 08/2013 - 06/2010
2	Shoulder Pain 08/2013 - 06/2010
1	Vomiting 04/2022
1	Nausea 04/2022
1	Synovitis 01/2022
1	Skin Manifestations 01/2022
1	Neoplasms (Cancer) 12/2021
1	Injection Site Reaction 12/2021
1	Tuberculosis (Tuberculoses) 12/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 11/2021
1	Heart Failure 01/2020
1	Pneumonia (Pneumonitis) 12/2018
1	Spondylarthropathies 10/2017
1	Osteoarthritis 04/2016
1	Musculoskeletal Diseases (Musculoskeletal Disease) 01/2016
1	Joint Diseases (Joint Disease) 11/2014
1	Chronic Obstructive Pulmonary Disease (COPD) 06/2013
1	Cutaneous Lupus Erythematosus 06/2013
1	Eczema 06/2013

Drug/Important Bio-Agent (IBA)

13	guselkumabIBA 03/2024 - 01/2020
11	Antirheumatic Agents (DMARD)IBA 04/2022 - 12/2015
9	Methotrexate (Mexate)FDA LinkGeneric 04/2022 - 07/2008
6	C-Reactive ProteinIBA 10/2021 - 08/2009
6	Biomarkers (Surrogate Marker)IBA 06/2021 - 07/2008
5	ametantrone (HAQ)IBA 09/2022 - 09/2016
5	InterleukinsIBA 09/2022 - 06/2015
4	Tumor Necrosis Factor InhibitorsIBA 03/2023 - 06/2013
4	tofacitinibIBA 01/2023 - 01/2021
3	Interleukin-23 Subunit p19IBA 09/2022 - 01/2020
3	Etanercept (Enbrel)FDA Link 01/2022 - 01/2019
3	ixekizumabIBA 01/2022 - 01/2020
3	Monoclonal AntibodiesIBA 12/2021 - 06/2013
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2021 - 08/2009
3	apremilastIBA 01/2020 - 06/2013
3	Interleukin-23 (Interleukin 23)IBA 01/2020 - 06/2015
3	Prostaglandins AIBA 01/2018 - 05/2011
3	Rheumatoid FactorIBA 10/2012 - 07/2005
2	Janus Kinase InhibitorsIBA 01/2023 - 09/2022
2	Leflunomide (Arava)FDA LinkGeneric 04/2022 - 02/2020
2	Adalimumab (Humira)FDA Link 01/2022 - 01/2020
2	HLA-B27 Antigen (HLA B27 Antigen)IBA 01/2021 - 01/2020
2	Interleukin-12 (IL 12)IBA 01/2020 - 06/2015
2	Ustekinumab (CNTO 1275)FDA Link 01/2020 - 06/2015
2	golimumab FDA Link 01/2018 - 05/2014
2	salicylhydroxamic acid (SHAM)IBA 04/2016 - 02/2012
2	Adrenal Cortex Hormones (Corticosteroids)IBA 08/2013 - 06/2010
2	Infliximab (Remicade)FDA Link 07/2010 - 06/2007
1	Immunoglobulin A (IgA)IBA 09/2022
1	Biosimilar PharmaceuticalsIBA 06/2022
1	Alanine Transaminase (SGPT)IBA 04/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	Interleukin-17 (Interleukin 17)IBA 01/2022
1	AntibodiesIBA 12/2021
1	Interleukin-17 ReceptorsIBA 01/2021
1	brodalumabIBA 01/2021
1	Biocompatible Materials (Biomaterials)IBA 06/2020
1	amsonic acid (DAS)IBA 01/2020
1	AntigensIBA 01/2020
1	Janus Kinase 1IBA 12/2018
1	GLPG0634IBA 12/2018
1	AsparagineIBA 10/2017
1	Amino Acids FDA Link 10/2017
1	N-phthaloylglutamic acidIBA 10/2017
1	Serine (L-Serine)FDA Link 10/2017
1	HLA-B Antigens (HLA-B)IBA 10/2017
1	HLA-C Antigens (HLA-C)IBA 10/2017
1	GadoliniumIBA 06/2017
1	CytokinesIBA 12/2016
1	ElementsIBA 12/2015
1	InterferonsIBA 06/2015
1	RoflumilastIBA 06/2013
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 06/2013
1	Phosphodiesterase 4 InhibitorsIBA 06/2013

Therapy/Procedure

17	Therapeutics 08/2023 - 07/2006
3	Drug Therapy (Chemotherapy) 06/2021 - 11/2014
3	Foot Orthoses 04/2016 - 07/2002
3	Orthotic Devices (Orthosis) 11/2007 - 07/2002
2	Exercise Therapy (Therapy, Exercise) 08/2013 - 06/2010
2	Biological Therapy 07/2013 - 11/2005
1	Immunomodulation 12/2016